Switch to:
Also traded in: Canada, Germany, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.16
NYSE:BIOA's Cash-to-Debt is ranked lower than
81% of the 1115 Companies
in the Global Chemicals industry.

( Industry Median: 0.76 vs. NYSE:BIOA: 0.16 )
Ranked among companies with meaningful Cash-to-Debt only.
NYSE:BIOA' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.15  Med: 2.44 Max: No Debt
Current: 0.16
Equity-to-Asset 0.47
NYSE:BIOA's Equity-to-Asset is ranked lower than
70% of the 1071 Companies
in the Global Chemicals industry.

( Industry Median: 0.56 vs. NYSE:BIOA: 0.47 )
Ranked among companies with meaningful Equity-to-Asset only.
NYSE:BIOA' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.3  Med: 0.41 Max: 0.91
Current: 0.47
0.3
0.91
Piotroski F-Score: 2
Altman Z-Score: -2.44
Beneish M-Score: -1.79
WACC vs ROIC
11.40%
-35.41%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating Margin % -305.92
NYSE:BIOA's Operating Margin % is ranked lower than
98% of the 1094 Companies
in the Global Chemicals industry.

( Industry Median: 7.85 vs. NYSE:BIOA: -305.92 )
Ranked among companies with meaningful Operating Margin % only.
NYSE:BIOA' s Operating Margin % Range Over the Past 10 Years
Min: -4796.79  Med: -1740.49 Max: -305.92
Current: -305.92
-4796.79
-305.92
Net Margin % -221.84
NYSE:BIOA's Net Margin % is ranked lower than
96% of the 1094 Companies
in the Global Chemicals industry.

( Industry Median: 5.68 vs. NYSE:BIOA: -221.84 )
Ranked among companies with meaningful Net Margin % only.
NYSE:BIOA' s Net Margin % Range Over the Past 10 Years
Min: -5468.04  Med: -1715.77 Max: -221.84
Current: -221.84
-5468.04
-221.84
ROE % -39.81
NYSE:BIOA's ROE % is ranked lower than
93% of the 1083 Companies
in the Global Chemicals industry.

( Industry Median: 8.97 vs. NYSE:BIOA: -39.81 )
Ranked among companies with meaningful ROE % only.
NYSE:BIOA' s ROE % Range Over the Past 10 Years
Min: -87.16  Med: -74.73 Max: -39.81
Current: -39.81
-87.16
-39.81
ROA % -15.26
NYSE:BIOA's ROA % is ranked lower than
90% of the 1122 Companies
in the Global Chemicals industry.

( Industry Median: 4.71 vs. NYSE:BIOA: -15.26 )
Ranked among companies with meaningful ROA % only.
NYSE:BIOA' s ROA % Range Over the Past 10 Years
Min: -68.83  Med: -34.11 Max: -14.83
Current: -15.26
-68.83
-14.83
ROC (Joel Greenblatt) % -20.60
NYSE:BIOA's ROC (Joel Greenblatt) % is ranked lower than
91% of the 1113 Companies
in the Global Chemicals industry.

( Industry Median: 14.66 vs. NYSE:BIOA: -20.60 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NYSE:BIOA' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -52059.13  Med: -188.57 Max: -20.6
Current: -20.6
-52059.13
-20.6
3-Year Revenue Growth Rate 19.10
NYSE:BIOA's 3-Year Revenue Growth Rate is ranked higher than
92% of the 989 Companies
in the Global Chemicals industry.

( Industry Median: 0.50 vs. NYSE:BIOA: 19.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NYSE:BIOA' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -11.8 Max: 19.1
Current: 19.1
0
19.1
3-Year EBITDA Growth Rate -22.10
NYSE:BIOA's 3-Year EBITDA Growth Rate is ranked lower than
93% of the 889 Companies
in the Global Chemicals industry.

( Industry Median: 8.60 vs. NYSE:BIOA: -22.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NYSE:BIOA' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -23.55 Max: -15.9
Current: -22.1
3-Year EPS without NRI Growth Rate -23.60
NYSE:BIOA's 3-Year EPS without NRI Growth Rate is ranked lower than
88% of the 817 Companies
in the Global Chemicals industry.

( Industry Median: 9.60 vs. NYSE:BIOA: -23.60 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NYSE:BIOA' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -25 Max: -15.8
Current: -23.6
GuruFocus has detected 6 Warning Signs with BioAmber Inc $NYSE:BIOA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NYSE:BIOA's 30-Y Financials

Financials (Next Earnings Date: 2017-11-03 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

BIOA Guru Trades in Q3 2016

Jim Simons 56,400 sh (New)
Chuck Royce 784,879 sh (-18.66%)
» More
Q4 2016

BIOA Guru Trades in Q4 2016

Chuck Royce 824,879 sh (+5.10%)
Jim Simons Sold Out
» More
Q1 2017

BIOA Guru Trades in Q1 2017

Chuck Royce 774,879 sh (-6.06%)
» More
Q2 2017

BIOA Guru Trades in Q2 2017

Chuck Royce 774,879 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with NYSE:BIOA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Chemicals    NAICS: 325199    SIC: 2819
Compare:XCNQ:ETI, TSX:RGX, TSXV:SGB, TSXV:IPD, XCNQ:OPC, TSX:MX » details
Traded in other countries:BIOA.Canada, 7BA.Germany, 0QSZ.UK,
Headquarter Location:Canada
BioAmber Inc is an industrial biotechnology company producing sustainable chemicals. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals.

BioAmber Inc was incorporated in the State of Delaware in October 15, 2008 and was established as the result of the spin-off of certain assets from Diversified Natural Products, Inc. The Company is an industrial biotechnology company producing sustainable chemicals. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are cost-competitive replacements for petroleum-derived chemicals, which are used in various everyday products including plastics, resins, food additives and personal care products. The Company currently sells its first product, bio-succinic acid, to customers in various chemical markets. The Company currently produces its bio-succinic acid in a large-scale demonstration facility using a 350,000 liter fermenter in Pomacle, France. It has produced approximately 2.35 million pounds, or 1,065 metric tons, of bio-succinic acid at this facility as of December 31, 2013. The Company is developing three distinct technologies: the production of succinic acid through fermentation; the conversion of succinic acid into 1,4 BDO, THF and GBL by catalyst assisted hydrogenation reaction; and the production of adipic acid and other C6 chemical intermediates through fermentation and purification. The Company is subject to various international, federal, state and local regulatory laws, rules and regulations.

Ratios

vs
industry
vs
history
PB Ratio 0.24
BIOA's PB Ratio is ranked higher than
65% of the 1065 Companies
in the Global Chemicals industry.

( Industry Median: 1.98 vs. BIOA: 0.24 )
Ranked among companies with meaningful PB Ratio only.
BIOA' s PB Ratio Range Over the Past 10 Years
Min: 0.23  Med: 2.67 Max: 7.14
Current: 0.24
0.23
7.14
PS Ratio 1.43
BIOA's PS Ratio is ranked lower than
93% of the 1072 Companies
in the Global Chemicals industry.

( Industry Median: 1.37 vs. BIOA: 1.43 )
Ranked among companies with meaningful PS Ratio only.
BIOA' s PS Ratio Range Over the Past 10 Years
Min: 1.4  Med: 45.98 Max: 148.98
Current: 1.43
1.4
148.98
EV-to-EBIT -2.06
BIOA's EV-to-EBIT is ranked lower than
99.99% of the 954 Companies
in the Global Chemicals industry.

( Industry Median: 15.68 vs. BIOA: -2.06 )
Ranked among companies with meaningful EV-to-EBIT only.
BIOA' s EV-to-EBIT Range Over the Past 10 Years
Min: -10.1  Med: -4.8 Max: 0.2
Current: -2.06
-10.1
0.2
EV-to-EBITDA -2.54
BIOA's EV-to-EBITDA is ranked lower than
99.99% of the 975 Companies
in the Global Chemicals industry.

( Industry Median: 12.03 vs. BIOA: -2.54 )
Ranked among companies with meaningful EV-to-EBITDA only.
BIOA' s EV-to-EBITDA Range Over the Past 10 Years
Min: -15.5  Med: -5 Max: 0.3
Current: -2.54
-15.5
0.3
Current Ratio 1.50
BIOA's Current Ratio is ranked lower than
77% of the 1091 Companies
in the Global Chemicals industry.

( Industry Median: 1.85 vs. BIOA: 1.50 )
Ranked among companies with meaningful Current Ratio only.
BIOA' s Current Ratio Range Over the Past 10 Years
Min: 0.37  Med: 2.49 Max: 11.06
Current: 1.5
0.37
11.06
Quick Ratio 1.03
BIOA's Quick Ratio is ranked lower than
73% of the 1091 Companies
in the Global Chemicals industry.

( Industry Median: 1.33 vs. BIOA: 1.03 )
Ranked among companies with meaningful Quick Ratio only.
BIOA' s Quick Ratio Range Over the Past 10 Years
Min: 0.31  Med: 2.19 Max: 10.84
Current: 1.03
0.31
10.84
Days Inventory 84.28
BIOA's Days Inventory is ranked lower than
68% of the 1052 Companies
in the Global Chemicals industry.

( Industry Median: 63.90 vs. BIOA: 84.28 )
Ranked among companies with meaningful Days Inventory only.
BIOA' s Days Inventory Range Over the Past 10 Years
Min: 83.42  Med: 197.97 Max: 292.45
Current: 84.28
83.42
292.45
Days Sales Outstanding 129.62
BIOA's Days Sales Outstanding is ranked higher than
93% of the 887 Companies
in the Global Chemicals industry.

( Industry Median: 62.15 vs. BIOA: 129.62 )
Ranked among companies with meaningful Days Sales Outstanding only.
BIOA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 43.55  Med: 108.13 Max: 868.83
Current: 129.62
43.55
868.83
Days Payable 69.10
BIOA's Days Payable is ranked higher than
65% of the 845 Companies
in the Global Chemicals industry.

( Industry Median: 49.97 vs. BIOA: 69.10 )
Ranked among companies with meaningful Days Payable only.
BIOA' s Days Payable Range Over the Past 10 Years
Min: 69.1  Med: 732.19 Max: 1677.21
Current: 69.1
69.1
1677.21

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -18.10
BIOA's 3-Year Average Share Buyback Ratio is ranked lower than
88% of the 570 Companies
in the Global Chemicals industry.

( Industry Median: -2.10 vs. BIOA: -18.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
BIOA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -40.6  Med: -27.3 Max: 0
Current: -18.1
-40.6
0

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 0.27
BIOA's Price-to-Tangible-Book is ranked higher than
63% of the 1024 Companies
in the Global Chemicals industry.

( Industry Median: 2.16 vs. BIOA: 0.27 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
BIOA' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.27  Med: 2.88 Max: 5.91
Current: 0.27
0.27
5.91
Price-to-Median-PS-Value 0.03
BIOA's Price-to-Median-PS-Value is ranked higher than
99% of the 1046 Companies
in the Global Chemicals industry.

( Industry Median: 1.28 vs. BIOA: 0.03 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
BIOA' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.03  Med: 0.95 Max: 2.79
Current: 0.03
0.03
2.79
Earnings Yield (Greenblatt) % -48.55
BIOA's Earnings Yield (Greenblatt) % is ranked lower than
94% of the 1118 Companies
in the Global Chemicals industry.

( Industry Median: 5.33 vs. BIOA: -48.55 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
BIOA' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -367  Med: -20.6 Max: 4093.3
Current: -48.55
-367
4093.3

More Statistics

Revenue (TTM) (Mil) $10.54
EPS (TTM) $ -0.76
Beta3.23
Short Percentage of Float12.59%
52-Week Range $0.45 - 6.50
Shares Outstanding (Mil)51.77

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 22 60 205
EPS ($) -0.48 -0.45 0.70
EPS without NRI ($) -0.48 -0.45 0.70
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for BIOA

Headlines

Articles On GuruFocus.com
BioAmber Inc. Announces Underwritten Offering of Common Stock and Warrants Aug 07 2017 
BioAmber announces record revenues for the second quarter 2017 and purchase of Mitsui equity stake i Aug 03 2017 
BioAmber Announces Webcast of Fiscal Second Quarter 2017 Financial Results Aug 01 2017 
BioAmber Launches a Pharmaceutical Grade for its Bio-succinic Acid Jun 15 2017 
BIOA ALERT: Rosen Law Firm Reminds BioAmber Inc. Investors of Important May 17 Deadline in First Fi May 16 2017 
BioAmber Announces Changes to its Board of Directors, the Appointment of a Chief Financial Officer a May 15 2017 
BioAmber Reports First Quarter 2017 Financial Results May 09 2017 
BioAmber Announces Trading on Toronto Stock Exchange Market Commencing on May 3, 2017 - Special Warr May 02 2017 
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against BioAmber Inc. an May 01 2017 
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against BioAmber In May 01 2017 

More From Other Websites
Edited Transcript of BIOA earnings conference call or presentation 3-Aug-17 12:30pm GMT Aug 13 2017
BioAmber Inc. Announces US$11 Million Underwritten Offering of Common Stock and Warrants Aug 08 2017
BioAmber Inc. Announces Underwritten Offering of Common Stock and Warrants Aug 07 2017
BioAmber reports 2Q loss Aug 04 2017
BioAmber announces record revenues for the second quarter 2017 and purchase of Mitsui equity stake... Aug 03 2017
Investor Network: BioAmber, Inc. to Host Earnings Call Aug 03 2017
BioAmber Announces Webcast of Fiscal Second Quarter 2017 Financial Results Aug 01 2017
BioAmber Launches a Pharmaceutical Grade for its Bio-succinic Acid Jun 15 2017
Edited Transcript of BIOA earnings conference call or presentation 9-May-17 8:30pm GMT Jun 08 2017
BIOA DEADLINE ALERT: The Law Offices of Vincent Wong Notifies Investors of BioAmber Inc. of... May 16 2017
Law Offices of Howard G. Smith Reminds BioAmber Inc. Investors of Pending Lawsuit and Upcoming Lead... May 16 2017
DEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against BioAmber Inc. and... May 16 2017
BIOA ALERT: Rosen Law Firm Reminds BioAmber Inc. Investors of Important May 17 Deadline in First... May 16 2017
UPCOMING DEADLINE ALERT: Levi & Korsinsky, LLP Reminds Shareholders of BioAmber Inc. of a Class... May 15 2017
2-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against BioAmber Inc.... May 15 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}